Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors

Purpose Telatinib is an orally active small-molecule tyrosine kinase inhibitor of kinase insert domain receptor (KDR; VEGFR-2) and fms-related tyrosine kinase 4 (FLT4; VEGFR-3). This study aims at the identification of relationships between single nucleotide polymorphisms (SNPs) in genes encoding fo...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Steeghs, Neeltje, Gelderblom, Hans, Wessels, Judith, Eskens, Ferry A. L. M., de Bont, Natasja, Nortier, Johan W. R., Guchelaar, Henk-Jan
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2009
Teme:
Phase I Studies
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3016151/
https://ncbi.nlm.nih.gov/pubmed/19924384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-009-9347-0
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki